Related Experiment Video
Updated: Aug 2, 2026

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog
Published on: November 5, 2014
A structural basis for mutational inactivation of the tumour suppressor Smad4
1Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York 10021, USA.
Abstract:
The Smad4/DPC4 tumour suppressor is inactivated in nearly half of pancreatic carcinomas and to a lesser extent in a variety of other cancers. Smad4/DPC4, and the related tumour suppressor Smad2, belong to the SMAD family of proteins that mediate signalling by the TGF-beta/activin/BMP-2/4 cytokine superfamily from receptor Ser/Thr protein kinases at the cell surface to the nucleus. SMAD proteins, which are phosphorylated by the activated receptor, propagate the signal, in part, through homo- and hetero-oligomeric interactions. Smad4/DPC4 plays a central role as it is the shared hetero-oligomerization partner of the other SMADs. The conserved carboxy-terminal domains of SMADs are sufficient for inducing most of the ligand-specific effects, and are the primary targets of tumorigenic inactivation. We now describe the crystal structure of the C-terminal domain (CTD) of the Smad4/DPC4 tumour suppressor, determined at 2.5 A resolution. The structure reveals that the Smad4/DPC4 CTD forms a crystallographic trimer through a conserved protein-protein interface, to which the majority of the tumour-derived missense mutations map. These mutations disrupt homo-oligomerization in vitro and in vivo, indicating that the trimeric assembly of the Smad4/DPC4 CTD is critical for signalling and is disrupted by tumorigenic mutations.
Insights
The Smad4/DPC4 tumor suppressor
Area of Science:
- Molecular Biology
- Cancer Research
- Structural Biology
Background:
- Smad4/DPC4 is a crucial tumor suppressor gene inactivated in pancreatic cancer and other malignancies.
- Smad proteins mediate signaling pathways for the TGF-beta cytokine superfamily.
- Smad4/DPC4 is essential for hetero-oligomerization among SMAD proteins, playing a central role in signal transduction.
Purpose of the Study:
- To determine the crystal structure of the C-terminal domain (CTD) of the Smad4/DPC4 tumor suppressor.
- To elucidate the structural basis for Smad4/DPC4 function and its inactivation in cancer.
Main Methods:
- X-ray crystallography at 2.5 A resolution to determine the structure of the Smad4/DPC4 CTD.
- Analysis of tumor-derived missense mutations in relation to the determined structure.
Main Results:
- The Smad4/DPC4 CTD forms a stable crystallographic trimer via a conserved protein-protein interface.
- The majority of cancer-associated missense mutations map to this trimeric interface.
- These mutations were shown to disrupt Smad4/DPC4 homo-oligomerization both in vitro and in vivo.
Conclusions:
- The trimeric assembly of the Smad4/DPC4 CTD is critical for its signaling function.
- Tumorigenic mutations in Smad4/DPC4 disrupt this essential trimeric structure, leading to impaired signaling.
- Understanding this structural mechanism provides insights into pancreatic cancer development.
More Related Videos
Related Concept Videos
Mismatch Repair
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
TGF - β Signaling Pathway
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

